mailwal

Why averages make bad plans look good

EUVC

Why averages make bad plans look good

The assumptions behind 2027 growth targets and fund strategies deserve more scrutiny than the headline numbers.

like
comment
share on facebook
share on twitter
share on threads
share on linkedin

As 2027 planning gets underway, averages can make fragile plans look convincing.

A single win rate, average deal size or rep quota can make a revenue plan add up even when the qualified market underneath it cannot support the target.

Venture funds face the same problem: one clean model can hide how much outcomes change when entry valuations, dilution, ownership, concentration or follow-on decisions move away from the base case.

The common risk is treating an assumption as if it were a fact. Plans become more useful when the inputs are tested against reality, the variables that matter most are made explicit and the model is exposed to different scenarios rather than one expected outcome.

For founders, that means rebuilding growth plans from the market upwards: who can genuinely buy, how much those accounts are worth and what conversion rates the market can realistically support. For investors, it means testing whether portfolio construction and return expectations still work when assumptions move against you.

This week, we’ve pulled together practical resources to help both groups identify where their plans are most fragile before those assumptions turn into expensive decisions.

Elsewhere in this edition, you’ll find updates from across European tech and venture, plus our latest snapshot of European funding rounds.

With 💖
David & Andreas

This week’s focus

For founders: Validate the market behind the target

Before adding headcount or committing to growth, test whether the market can actually support the plan. That means looking beyond top-down targets to the size, quality and buying behaviour of the customers underneath them.

For investors: Challenge the assumptions behind the fund

A fund model can look convincing while depending on assumptions that are too neat. Test whether the strategy still works when valuations, dilution, ownership, portfolio construction or follow-on decisions move away from the base case.

Also worth exploring

Podcasts

Building for healthcare means trading breadth for the depth required in a highly specialised market.

Andreas Cleve, Co-Founder and CEO of Corti, explains how clinical accuracy, workflow integration and in-house compliance can turn constraints into core company capabilities.

Founders need clarity on where investors can genuinely help, while VCs need to know when their experience is relevant.

Dan Bowyer and Mads Jensen of SuperSeed discuss how both sides can build a more effective partnership.

From the EUVC Summit 2026 stage

Holding on to winners maximises potential upside, but without liquidity, paper gains cannot deliver returns to LPs.

Romain Lavault of Partech and Joe Schorge of Isomer Capital discuss how seed funds can use secondaries, liquidity planning and disciplined selling to balance DPI with long-term upside.

Investors need more than a compelling idea or a strong company. They need a clear problem, a credible solution and a reason to act now.

Denes Ban of RAISE explains why fundraising should be treated as a measurable system, how to identify conversion bottlenecks and why numbers, storytelling and urgency must work together.

Latest European funding rounds

fb
tw
ig
yt
in

Update your email preferences or unsubscribe here

© 2026 EUVC

17a Curzon Street
London, London W1J 5HS, United Kingdom